PROGNOSTIC IMPLICATION OF ESTROGEN-RECEPTOR CONTENT IN BREAST-CANCER

被引：44
作者：
ADAMI, HO
GRAFFMAN, S
LINDGREN, A
SALLSTROM, J
机构：
[1] UNIV HOSP UPPSALA, DEPT ONCOL, S-75185 UPPSALA, SWEDEN
[2] UNIV HOSP UPPSALA, DEPT CLIN PATHOL, S-75185 UPPSALA, SWEDEN
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1985年 / 5卷 / 03期
关键词：
D O I：
10.1007/BF01806024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：293 / 300
页数：8
相关论文
共 34 条
  • [1] ACKERMAN LV, 1968, SURGICAL PATHOLOGY, P736
  • [2] SURVIVAL AND RECURRENCES 5 YEARS AFTER SELECTIVE TREATMENT FOR BREAST CARCINOMA
    ADAMI, HO
    GRAFFMAN, S
    JOHANSSON, H
    RIMSTEN, A
    [J]. BRITISH JOURNAL OF CANCER, 1978, 38 (05) : 624 - 630
  • [3] ADAMI HO, 1984, ACTA CHIR SCAND, P25
  • [4] MARKERS AND PROGNOSTIC FACTORS IN BREAST-CANCER DISEASE - WORKSHOP REPORT
    ANDERSEN, JA
    MATTHEIEM, WH
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (12): : 1699 - 1707
  • [5] BISHOP HM, 1979, LANCET, V2, P283
  • [6] Burton K, 1968, METHODS ENZYMOLOGY B, V12, P163
  • [7] CAMPBELL FC, 1983, 3RD EORTC BREAST CAN
  • [8] ESTROGEN-RECEPTORS AND SURVIVAL IN EARLY BREAST-CANCER
    CROTON, R
    COOKE, T
    HOLT, S
    GEORGE, WD
    NICOLSON, R
    GRIFFITHS, K
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6302): : 1289 - 1291
  • [9] CROWE JH, 1982, MOL PHYSIOL, V2, P171
  • [10] FERNO M, 1983, ANTICANCER RES, V3, P243
1234